(Q33794095)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10597386%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

review article

1 reference

title

Treatment options for bleeding episodes in patients undergoing immune tolerance therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10597386%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10597386%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

author name string

Manno CS

series ordinal

1

1 reference

29 July 2017

publication date

1 September 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10597386%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10597386%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

5 Suppl 3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10597386%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

33-41

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10597386%20AND%20SRC:MED&resulttype=core&format=json

Inhibitors in hemophilia patients: current status and management

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1999.00035.X

Incidence of development of factor VIII and factor IX inhibitors in haemophiliacs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1999.00035.X

Immune tolerance: a synopsis of the international experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1999.00035.X

Recombinant factor VIII for the treatment of previously untreated patients with hemophilia A. Safety, efficacy, and development of inhibitors. Kogenate Previously Untreated Patient Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1999.00035.X

Quinolone toxicity: methods of assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1999.00035.X

Induction of immune tolerance in patients with hemophilia and antibodies to factor VIII by combined treatment with intravenous IgG, cyclophosphamide, and factor VIII.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1999.00035.X

Home treatment with recombinant activated factor VII in patients with factor VIII inhibitors: the advantages of early intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1999.00035.X

The effect of activated prothrombin-complex concentrate (FEIBA) on joint and muscle bleeding in patients with hemophilia A and antibodies to factor VIII. A double-blind clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1999.00035.X

Efficacy of prothrombin-complex concentrates in hemophiliacs with antibodies to factor VIII: a multicenter therapeutic trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1999.00035.X

Use of plasma-derived factor VIIa in a child with inhibitors of FVIII for the placement of an implantable intravenous access device

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1999.00035.X

Use of human factor VIIa in the treatment of two hemophilia A patients with high-titer inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1999.00035.X

Laboratory evidence of DIC under FEIBA treatment of a hemophilic patient with intracranial bleeding and high titre factor VIII inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1999.00035.X

Disseminated intravascular coagulation and infusion of factor-VIII-inhibitor bypassing activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1999.00035.X

10.1046/J.1365-2516.1999.00035.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10597386%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference